The Neuromodulation Research Center (NMRC) is one of a few centers in the United States that has as its major mission investigating and understanding the causes and development of diseases of the human central nervous system (CNS).
Formed in 2006 within the Lerner Research Institute (LRI), the NMRC incorporates investigators from the LRI's Departments of Neuroscience and Biomedical Engineering as well as faculty from the Cleveland Clinic's Departments of Neurology, Neurological Surgery and Radiology. The NMRC is unique in that it uses a multi-disciplinary approach to understanding how neurological diseases are caused and progress within the CNS. The NMRC then works to translate these understandings into better patient care.
Jerrold Vitek, M.D., Ph.D., is the Director of the Neuromodulation Research Center. His research team focuses on medical and surgical treatment of movement disorders including Parkinson's disease, dystonia, and tremor. The center focuses on the functional and physical changes in patients with movement disorders, the mechanisms of Deep Brain Stimulation (DBS), and the development of new applications for DBS.
To treat neurological diseases, particularly movement disorders such as Parkinson's disease and dystonia.
To understand how changes to a patient's anatomy and body functions affect or influence neurological diseases.
Take what is learned in the laboratory and translate it into better and more effective patient care.
Applying surgical therapy and DBS for neurological disease, improving present technology, and exploring new applications for this technology.